Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2019 | 140 | 0.700 |
Why?
|
| Triiodothyronine | 2 | 2016 | 497 | 0.630 |
Why?
|
| Glucagon | 1 | 2016 | 533 | 0.530 |
Why?
|
| Cathepsin B | 1 | 2010 | 90 | 0.380 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 656 | 0.370 |
Why?
|
| Tretinoin | 1 | 2011 | 530 | 0.340 |
Why?
|
| Blood Platelets | 1 | 2019 | 2474 | 0.340 |
Why?
|
| Liver Neoplasms | 3 | 2019 | 4091 | 0.340 |
Why?
|
| Silymarin | 3 | 2013 | 22 | 0.330 |
Why?
|
| NF-kappa B | 1 | 2010 | 2579 | 0.210 |
Why?
|
| Kupffer Cells | 1 | 2019 | 158 | 0.170 |
Why?
|
| Liver | 4 | 2019 | 7647 | 0.170 |
Why?
|
| Glioblastoma | 2 | 2011 | 3352 | 0.170 |
Why?
|
| Intestinal Neoplasms | 1 | 2020 | 297 | 0.160 |
Why?
|
| Antineoplastic Agents | 2 | 2011 | 13732 | 0.160 |
Why?
|
| Chemical Engineering | 1 | 2016 | 15 | 0.160 |
Why?
|
| Caspase 8 | 1 | 2017 | 209 | 0.160 |
Why?
|
| Body Weight | 2 | 2019 | 4692 | 0.150 |
Why?
|
| Cytoplasmic Granules | 1 | 2019 | 621 | 0.150 |
Why?
|
| Hepatitis E virus | 1 | 2017 | 71 | 0.150 |
Why?
|
| Platelet Count | 1 | 2019 | 795 | 0.150 |
Why?
|
| Endothelium | 1 | 2019 | 804 | 0.150 |
Why?
|
| Platelet Aggregation | 1 | 2019 | 808 | 0.140 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 496 | 0.140 |
Why?
|
| Hepatocytes | 2 | 2019 | 1249 | 0.130 |
Why?
|
| Carcinoma | 2 | 2020 | 2325 | 0.130 |
Why?
|
| Drug Synergism | 2 | 2016 | 1878 | 0.130 |
Why?
|
| Cell Differentiation | 1 | 2011 | 11746 | 0.120 |
Why?
|
| Cell Nucleus Size | 1 | 2011 | 12 | 0.110 |
Why?
|
| Arsenicals | 1 | 2011 | 122 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2016 | 1941 | 0.100 |
Why?
|
| Cystatin A | 1 | 2010 | 5 | 0.100 |
Why?
|
| Cell Dedifferentiation | 1 | 2011 | 141 | 0.100 |
Why?
|
| Cell Shape | 1 | 2011 | 379 | 0.100 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2010 | 83 | 0.100 |
Why?
|
| Oxides | 1 | 2011 | 425 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 9923 | 0.090 |
Why?
|
| Cell Size | 1 | 2011 | 660 | 0.090 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 16943 | 0.090 |
Why?
|
| Viral Proteins | 1 | 2017 | 1975 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 631 | 0.090 |
Why?
|
| Cell Proliferation | 4 | 2017 | 10800 | 0.090 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 3062 | 0.090 |
Why?
|
| RNA, Viral | 1 | 2017 | 2831 | 0.090 |
Why?
|
| Antigens, Differentiation | 1 | 2011 | 967 | 0.080 |
Why?
|
| Hyperglycemia | 1 | 2016 | 1359 | 0.080 |
Why?
|
| Thyroxine | 1 | 2011 | 653 | 0.080 |
Why?
|
| Cholesterol | 1 | 2016 | 2896 | 0.080 |
Why?
|
| DNA Damage | 1 | 2017 | 2467 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 3004 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 1177 | 0.070 |
Why?
|
| Bone and Bones | 1 | 2016 | 2566 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2017 | 2085 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 2234 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2862 | 0.070 |
Why?
|
| Cytokines | 1 | 2019 | 7225 | 0.060 |
Why?
|
| Apoptosis | 3 | 2020 | 10112 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 3702 | 0.060 |
Why?
|
| Melanoma | 1 | 2021 | 5274 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 18345 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2016 | 3256 | 0.050 |
Why?
|
| Cell Survival | 1 | 2011 | 6131 | 0.050 |
Why?
|
| Animals | 5 | 2021 | 170726 | 0.050 |
Why?
|
| Mice | 4 | 2021 | 80995 | 0.040 |
Why?
|
| Thyroid Neoplasms | 1 | 2011 | 2229 | 0.040 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2017 | 29 | 0.040 |
Why?
|
| Gene Expression | 1 | 2011 | 8010 | 0.040 |
Why?
|
| Melanocytes | 1 | 2021 | 523 | 0.040 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2017 | 119 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2017 | 255 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2017 | 841 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 8674 | 0.040 |
Why?
|
| Liver Regeneration | 1 | 2017 | 222 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 467 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 574 | 0.030 |
Why?
|
| Epitopes | 1 | 2021 | 2654 | 0.030 |
Why?
|
| Obesity | 1 | 2016 | 12192 | 0.030 |
Why?
|
| Hepatectomy | 1 | 2017 | 564 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 10980 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2017 | 698 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 2002 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2017 | 1988 | 0.030 |
Why?
|
| Humans | 9 | 2021 | 715124 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 393 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2013 | 481 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 8804 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2013 | 768 | 0.020 |
Why?
|
| Endoscopy | 1 | 2020 | 1754 | 0.020 |
Why?
|
| Hepatitis B virus | 1 | 2013 | 454 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 702 | 0.020 |
Why?
|
| DNA Repair | 1 | 2017 | 2059 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3687 | 0.020 |
Why?
|
| Histones | 1 | 2017 | 2580 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 8738 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2020 | 2272 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 11766 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2017 | 9022 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 70704 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 29442 | 0.010 |
Why?
|
| Male | 1 | 2017 | 351081 | 0.000 |
Why?
|
| Female | 1 | 2017 | 377334 | 0.000 |
Why?
|
Concepts
(101)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_